{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T05:22:38Z","timestamp":1793510558714,"version":"4.5.0"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T00:00:00Z","timestamp":1752710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003705","name":"Korea Institute of Toxicology","doi-asserted-by":"publisher","award":["1711195889"],"award-info":[{"award-number":["1711195889"]}],"id":[{"id":"10.13039\/501100003705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003705","name":"Korea Institute of Toxicology","doi-asserted-by":"publisher","award":["2710008763"],"award-info":[{"award-number":["2710008763"]}],"id":[{"id":"10.13039\/501100003705","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003569","name":"Ministry of Food and Drug Safety","doi-asserted-by":"publisher","award":["22213MFDS391"],"award-info":[{"award-number":["22213MFDS391"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-08855-w","type":"journal-article","created":{"date-parts":[[2025,7,17]],"date-time":"2025-07-17T17:41:44Z","timestamp":1752774104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Chronic haloperidol exposure impairs neurodevelopment via Notch1 signaling in human stem cell-derived brain organoids"],"prefix":"10.1038","volume":"15","author":[{"given":"Hyunsu","family":"Kang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Hyeok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hana","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki-Suk","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,17]]},"reference":[{"key":"8855_CR1","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1002\/med.21512","volume":"39","author":"XF Huang","year":"2019","unstructured":"Huang, X. F. & Song, X. Effects of antipsychotic drugs on neurites relevant to schizophrenia treatment. Med. Res. Rev. 39, 386\u2013403 (2019).","journal-title":"Med. Res. Rev."},{"key":"8855_CR2","doi-asserted-by":"crossref","unstructured":"Orzelska-G\u00f3rka, J., Mikulska, J., Wiszniewska, A. & Bia\u0142a, G. New atypical antipsychotics in the treatment of schizophrenia and depression. Int J. Mol. Sci 23, 10624 (2022).","DOI":"10.3390\/ijms231810624"},{"key":"8855_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11920-021-01298-w","volume":"23","author":"M Pahwa","year":"2021","unstructured":"Pahwa, M., Sleem, A., Elsayed, O. H., Good, M. E. & El-Mallakh, R. S. New antipsychotic medications in the last decade. Curr. Psychiatry Rep. 23, 87 (2021).","journal-title":"Curr. Psychiatry Rep."},{"key":"8855_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-642-25761-2_2","volume":"212","author":"N Ginovart","year":"2012","unstructured":"Ginovart, N. & Kapur, S. Role of dopamine D(2) receptors for antipsychotic activity. Handb. Exp. Pharmacol. 212, 27\u201352 (2012).","journal-title":"Handb. Exp. Pharmacol."},{"key":"8855_CR5","doi-asserted-by":"crossref","unstructured":"Gomes, F. V. & Grace, A. A. Beyond dopamine receptor antagonism: new targets for schizophrenia treatment and prevention. Int J. Mol. Sci 22, 4467  (2021).","DOI":"10.3390\/ijms22094467"},{"key":"8855_CR6","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1111\/j.1471-4159.2011.07590.x","volume":"120","author":"S Jafari","year":"2012","unstructured":"Jafari, S., Fernandez-Enright, F. & Huang, X. F. Structural contributions of antipsychotic drugs to their therapeutic profiles and metabolic side effects. J. Neurochem. 120, 371\u2013384 (2012).","journal-title":"J. Neurochem"},{"key":"8855_CR7","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1097\/00004714-200106000-00002","volume":"21","author":"K Hatta","year":"2001","unstructured":"Hatta, K. et al. The association between intravenous haloperidol and prolonged QT interval. J. Clin. Psychopharmacol. 21, 257\u2013261 (2001).","journal-title":"J. Clin. Psychopharmacol."},{"key":"8855_CR8","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1139\/jpn.0732","volume":"32","author":"Y Dai","year":"2007","unstructured":"Dai, Y. et al. Haloperidol induces the nuclear translocation of phosphatidylinositol 3\u2032-kinase to disrupt Akt phosphorylation in PC12 cells. J. Psychiatry Neurosci. 32, 323\u2013330 (2007).","journal-title":"J. Psychiatry Neurosci."},{"key":"8855_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3389\/fnins.2018.00743","volume":"12","author":"M Hu","year":"2018","unstructured":"Hu, M. et al. Propionate protects haloperidol-induced neurite lesions mediated by neuropeptide Y. Front. Neurosci. 12, 743 (2018).","journal-title":"Front. Neurosci."},{"key":"8855_CR10","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1038\/sj.npp.1300710","volume":"30","author":"KA Dorph-Petersen","year":"2005","unstructured":"Dorph-Petersen, K. A. et al. The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology 30, 1649\u20131661 (2005).","journal-title":"Neuropsychopharmacology"},{"key":"8855_CR11","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1001\/archgenpsychiatry.2010.199","volume":"68","author":"BC Ho","year":"2011","unstructured":"Ho, B. C., Andreasen, N. C., Ziebell, S., Pierson, R. & Magnotta, V. Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch. Gen. Psychiatry. 68, 128\u2013137 (2011).","journal-title":"Arch. Gen. Psychiatry"},{"key":"8855_CR12","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.taap.2018.02.008","volume":"354","author":"A Bal-Price","year":"2018","unstructured":"Bal-Price, A. et al. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods. Toxicol. Appl. Pharmacol. 354, 7\u201318 (2018b).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"8855_CR13","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ntt.2007.06.002","volume":"30","author":"KM Crofton","year":"2008","unstructured":"Crofton, K. M. et al. Undertaking positive control studies as part of developmental neurotoxicity testing: a report from the ILSI research foundation\/risk science Institute expert working group on neurodevelopmental endpoints. Neurotoxicol Teratol. 30, 266\u2013287 (2008).","journal-title":"Neurotoxicol Teratol"},{"key":"8855_CR14","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1741-4520.2012.00374.x","volume":"52","author":"R Tsuji","year":"2012","unstructured":"Tsuji, R. & Crofton, K. M. Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation. Congenit Anom. 52, 122\u2013128 (2012).","journal-title":"Congenit Anom."},{"key":"8855_CR15","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.ntt.2004.02.007","volume":"26","author":"KM Crofton","year":"2004","unstructured":"Crofton, K. M., Makris, S. L., Sette, W. F., Mendez, E. & Raffaele, K. C. A qualitative retrospective analysis of positive control data in developmental neurotoxicity studies. Neurotoxicol Teratol. 26, 345\u2013352 (2004).","journal-title":"Neurotoxicol Teratol"},{"key":"8855_CR16","doi-asserted-by":"crossref","unstructured":"Han, J. J. FDA Modernization Act 2.0 Allows for Alternatives To Animal Testing (Wiley Online Library, 2023).","DOI":"10.1111\/aor.14503"},{"key":"8855_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s43188-023-00215-y","volume":"40","author":"Y Uesawa","year":"2024","unstructured":"Uesawa, Y. Efficiency of pharmaceutical toxicity prediction in computational toxicology. Toxicol 40, 1\u20139 (2024).","journal-title":"Toxicol"},{"key":"8855_CR18","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1089\/scd.2014.0531","volume":"24","author":"JG Hunsberger","year":"2015","unstructured":"Hunsberger, J. G. et al. Induced pluripotent stem cell models to enable in vitro models for screening in the central nervous system. Stem Cells Dev. 24, 1852\u20131864 (2015).","journal-title":"Stem Cells Dev."},{"key":"8855_CR19","doi-asserted-by":"crossref","unstructured":"Ryan, K. R. et al. Neurite outgrowth in human induced pluripotent stem cell-derived neurons as a high-throughput screen for developmental neurotoxicity or neurotoxicity. Neurotoxicology 53, 271\u2013281 (2016).","DOI":"10.1016\/j.neuro.2016.02.003"},{"key":"8855_CR20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-024-01809-0","volume":"9","author":"J Cerneckis","year":"2024","unstructured":"Cerneckis, J., Cai, H. & Shi, Y. Induced pluripotent stem cells (iPSCs): molecular mechanisms of induction and applications. Signal. Transduct. Target. Ther. 9, 112 (2024).","journal-title":"Signal. Transduct. Target. Ther."},{"key":"8855_CR21","doi-asserted-by":"publisher","first-page":"102063","DOI":"10.1016\/j.isci.2021.102063","volume":"24","author":"J Kim","year":"2021","unstructured":"Kim, J., Sullivan, G. J. & Park, I. H. How well do brain organoids capture your brain? iScience 24, 102063 (2021).","journal-title":"iScience"},{"key":"8855_CR22","doi-asserted-by":"publisher","first-page":"12528","DOI":"10.3390\/ijms241512528","volume":"24","author":"SH Kim","year":"2023","unstructured":"Kim, S. H. & Chang, M. Y. Application of human brain organoids\u2014opportunities and challenges in modeling human brain development and neurodevelopmental diseases. Int. J. Mol. Sci. 24, 12528 (2023).","journal-title":"Int. J. Mol. Sci."},{"key":"8855_CR23","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen, J. et al. Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309, 1696\u20131703 (2013).","journal-title":"JAMA"},{"key":"8855_CR24","doi-asserted-by":"crossref","unstructured":"Hatakeyama, J. & Kageyama, R. Notch1 expression is spatiotemporally correlated with neurogenesis and negatively regulated by Notch1-independent Hes genes in the developing nervous system. Cereb. Cortex 16(suppl 1)(suppl_1):i132-i137, i132\u2013i137 (2006).","DOI":"10.1093\/cercor\/bhj166"},{"key":"8855_CR25","doi-asserted-by":"crossref","unstructured":"Sachan, N., Mutsuddi, M. & Mukherjee, A. Notch signaling: from neurogenesis to neurodegeneration. Insights Hum. Neurodegener Lessons Learnt Drosophila, 7, 185\u2013221 (2019).","DOI":"10.1007\/978-981-13-2218-1_7"},{"key":"8855_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s00441-017-2641-9","volume":"371","author":"R Zhang","year":"2018","unstructured":"Zhang, R., Engler, A. & Taylor, V. Notch: an interactive player in neurogenesis and disease. Cell. Tissue Res. 371, 73\u201389 (2018).","journal-title":"Cell. Tissue Res."},{"key":"8855_CR27","doi-asserted-by":"publisher","first-page":"447","DOI":"10.3389\/fncel.2015.00447","volume":"9","author":"E Brai","year":"2015","unstructured":"Brai, E. et al. Notch1 regulates hippocampal plasticity through interaction with the reelin pathway, glutamatergic transmission and CREB signaling. Front. Cell. Neurosci. 9, 447 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"8855_CR28","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41378-020-0165-z","volume":"6","author":"K Cui","year":"2020","unstructured":"Cui, K. et al. Neurodevelopmental impairment induced by prenatal valproic acid exposure shown with the human cortical organoid-on-a-chip model. Microsyst. Nanoeng. 6, 49 (2020).","journal-title":"Microsyst. Nanoeng"},{"key":"8855_CR29","doi-asserted-by":"publisher","first-page":"1023765","DOI":"10.3389\/fnmol.2022.1023765","volume":"15","author":"Z Zang","year":"2022","unstructured":"Zang, Z. et al. Valproic acid exposure decreases neurogenic potential of outer radial glia in human brain organoids. Front. Mol. Neurosci. 15, 1023765 (2022).","journal-title":"Front. Mol. Neurosci."},{"key":"8855_CR30","doi-asserted-by":"publisher","first-page":"pyv088","DOI":"10.1093\/ijnp\/pyv088","volume":"19","author":"HN Wang","year":"2015","unstructured":"Wang, H. N. et al. Quetiapine ameliorates schizophrenia-like behaviors and protects Myelin integrity in Cuprizone intoxicated mice: the involvement of Notch signaling pathway. Int. J. Neuropsychopharmacol. 19, pyv088 (2015).","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"8855_CR31","doi-asserted-by":"crossref","unstructured":"Rehman, M. et al. High-throughput screening discovers antifibrotic properties of haloperidol by hindering myofibroblast activation. JCI Insight 4, 8 (2019).","DOI":"10.1172\/jci.insight.123987"},{"key":"8855_CR32","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s12311-020-01193-9","volume":"20","author":"P Chauhan","year":"2021","unstructured":"Chauhan, P., Garg, S., Tikka, S. K. & Khattri, S. Efficacy of intensive cerebellar intermittent theta burst stimulation (iCiTBS) in treatment-resistant schizophrenia: a randomized placebo-controlled study. Cerebellum 20, 116\u2013123 (2021).","journal-title":"Cerebellum"},{"key":"8855_CR33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.taap.2018.04.001","volume":"354","author":"JA Harrill","year":"2018","unstructured":"Harrill, J. A. et al. Testing for developmental neurotoxicity using a battery of in vitro assays for key cellular events in neurodevelopment. Toxicol. Appl. Pharmacol. 354, 24\u201339 (2018).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"8855_CR34","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.tins.2020.05.004","volume":"43","author":"I Parenti","year":"2020","unstructured":"Parenti, I., Rabaneda, L. G., Schoen, H. & Novarino, G. Neurodevelopmental disorders: from genetics to functional pathways. Trends Neurosci. 43, 608\u2013621 (2020).","journal-title":"Trends Neurosci."},{"issue":"suppl 3","key":"8855_CR35","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1289\/ehp.00108s3511","volume":"108","author":"D Rice","year":"2000","unstructured":"Rice, D. & Barone, S. Jr Critical periods of vulnerability for the developing nervous system: evidence from humans and animal models. Environ. Health Perspect. 108 (suppl 3), 511\u2013533 (2000).","journal-title":"Environ. Health Perspect."},{"key":"8855_CR36","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.ntt.2010.04.053","volume":"32","author":"KC Raffaele","year":"2010","unstructured":"Raffaele, K. C. et al. The use of developmental neurotoxicity data in pesticide risk assessments. Neurotoxicol Teratol. 32, 563\u2013572 (2010).","journal-title":"Neurotoxicol Teratol"},{"key":"8855_CR37","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1093\/toxsci\/kfz052","volume":"169","author":"TJ Shafer","year":"2019","unstructured":"Shafer, T. J. et al. Evaluation of chemical effects on network formation in cortical neurons grown on microelectrode arrays. Toxicol. Sci. 169, 436\u2013455 (2019).","journal-title":"Toxicol. Sci."},{"key":"8855_CR38","doi-asserted-by":"publisher","first-page":"306","DOI":"10.14573\/altex.1712081","volume":"35","author":"A Bal-Price","year":"2018","unstructured":"Bal-Price, A. et al. Recommendation on test readiness criteria for new approach methods (NAM) in toxicology: exemplified for developmental neurotoxicity (DNT). ALTEX 35, 306\u2013352 (2018a).","journal-title":"ALTEX"},{"key":"8855_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00204-016-1805-9","volume":"91","author":"BZ Schmidt","year":"2017","unstructured":"Schmidt, B. Z. et al. In vitro acute and developmental neurotoxicity screening: an overview of cellular platforms and high-throughput technical possibilities. Arch. Toxicol. 91, 1\u201333 (2017).","journal-title":"Arch. Toxicol."},{"key":"8855_CR40","first-page":"49","volume":"34","author":"M Aschner","year":"2017","unstructured":"Aschner, M. et al. Reference compounds for alternative test methods to indicate developmental neurotoxicity (DNT) potential of chemicals: example lists and criteria for their selection and use. ALTEX 34, 49\u201374 (2017).","journal-title":"ALTEX"},{"key":"8855_CR41","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.stem.2008.09.002","volume":"3","author":"M Eiraku","year":"2008","unstructured":"Eiraku, M. et al. Self-organized formation of polarized cortical tissues from ESCs and its active manipulation by extrinsic signals. Cell. Stem Cell. 3, 519\u2013532 (2008).","journal-title":"Cell. Stem Cell."},{"key":"8855_CR42","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1124\/jpet.113.209031","volume":"347","author":"EJ Hutchings","year":"2013","unstructured":"Hutchings, E. J., Waller, J. L. & Terry, A. V. Differential long-term effects of haloperidol and Risperidone on the acquisition and performance of tasks of Spatial working and short-term memory and sustained attention in rats. J. Pharmacol. Exp. Ther. 347, 547\u2013556 (2013).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"8855_CR43","doi-asserted-by":"publisher","first-page":"107743","DOI":"10.1016\/j.neuropharm.2019.107743","volume":"158","author":"T Gener","year":"2019","unstructured":"Gener, T. et al. Serotonin 5-HT1A, 5-HT2A and dopamine D2 receptors strongly influence prefronto-hippocampal neural networks in alert mice: contribution to the actions of Risperidone. Neuropharmacology 158, 107743 (2019).","journal-title":"Neuropharmacology"},{"key":"8855_CR44","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.2174\/1568026616666160608084834","volume":"16","author":"P Li","year":"2016","unstructured":"Li, P., Snyder, G. L. & Vanover, K. E. Dopamine targeting drugs for the treatment of schizophrenia: past, present and future. Curr. Top. Med. Chem. 16, 3385\u20133403 (2016).","journal-title":"Curr. Top. Med. Chem."},{"key":"8855_CR45","doi-asserted-by":"publisher","first-page":"10484","DOI":"10.1523\/JNEUROSCI.4721-09.2010","volume":"30","author":"JL Ables","year":"2010","unstructured":"Ables, J. L. et al. Notch1 is required for maintenance of the reservoir of adult hippocampal stem cells. J. Neurosci. 30, 10484\u201310492 (2010).","journal-title":"J. Neurosci."},{"key":"8855_CR46","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/iub.362","volume":"62","author":"ZD Zhou","year":"2010","unstructured":"Zhou, Z. D., Kumari, U., Xiao, Z. C. & Tan, E. K. Notch as a molecular switch in neural stem cells. IUBMB Life. 62, 618\u2013623 (2010).","journal-title":"IUBMB Life"},{"key":"8855_CR47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1097\/00004714-200006000-00011","volume":"20","author":"AA Wassef","year":"2000","unstructured":"Wassef, A. A. et al. Randomized, placebo-controlled pilot study of divalproex sodium in the treatment of acute exacerbations of chronic schizophrenia. J. Clin. Psychopharmacol. 20, 357\u2013361 (2000).","journal-title":"J. Clin. Psychopharmacol."},{"key":"8855_CR48","first-page":"43","volume":"16","author":"H Kang","year":"2022","unstructured":"Kang, H. et al. Assessment of neurotoxicity on neurite outgrowth in human induced pluripotent stem cell-derived neurons using high-content screening. JSAAE 16, 43\u201352 (2022).","journal-title":"JSAAE"},{"key":"8855_CR49","doi-asserted-by":"publisher","first-page":"100443","DOI":"10.1016\/j.xpro.2021.100443","volume":"2","author":"H Kim","year":"2021","unstructured":"Kim, H. & Jiang, P. Generation of human pluripotent stem cell-derived fused organoids with oligodendroglia and Myelin. STAR. Protocols. 2, 100443 (2021).","journal-title":"STAR. Protocols"},{"key":"8855_CR50","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1016\/j.cell.2016.04.032","volume":"165","author":"X Qian","year":"2016","unstructured":"Qian, X. et al. Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165, 1238\u20131254 (2016).","journal-title":"Cell"},{"key":"8855_CR51","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1038\/s41592-023-02080-x","volume":"20","author":"D Reumann","year":"2023","unstructured":"Reumann, D. et al. In vitro modeling of the human dopaminergic system using spatially arranged ventral midbrain-striatum-cortex assembloids. Nat. Methods. 20, 2034\u20132047 (2023).","journal-title":"Nat. Methods"},{"key":"8855_CR52","doi-asserted-by":"publisher","first-page":"260","DOI":"10.3389\/fncel.2013.00260","volume":"7","author":"KM Money","year":"2013","unstructured":"Money, K. M. & Stanwood, G. D. Developmental origins of brain disorders: roles for dopamine. Front. Cell. Neurosci. 7, 260 (2013).","journal-title":"Front. Cell. Neurosci."},{"key":"8855_CR53","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1002\/stem.408","volume":"28","author":"L Borghese","year":"2010","unstructured":"Borghese, L. et al. Inhibition of Notch signaling in human embryonic stem cell-derived neural stem cells delays G1\/S phase transition and accelerates neuronal differentiation in vitro and in vivo. Stem Cells. 28, 955\u2013964 (2010).","journal-title":"Stem Cells"},{"key":"8855_CR54","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1089\/cell.2017.0009","volume":"19","author":"K Venkatesh","year":"2017","unstructured":"Venkatesh, K. et al. NOTCH signaling is essential for maturation, self-renewal, and tri-differentiation of in vitro derived human neural stem cells. Cell. Reprogramming. 19, 372\u2013383 (2017).","journal-title":"Cell. Reprogramming"},{"key":"8855_CR55","doi-asserted-by":"publisher","first-page":"e1000565","DOI":"10.1371\/journal.pbio.1000565","volume":"8","author":"V Kaltezioti","year":"2010","unstructured":"Kaltezioti, V. et al. Prox1 regulates the Notch1-mediated Inhibition of neurogenesis. PLoS Biol. 8, e1000565 (2010).","journal-title":"PLoS Biol."},{"key":"8855_CR56","doi-asserted-by":"publisher","first-page":"2329","DOI":"10.1038\/nprot.2014.158","volume":"9","author":"MA Lancaster","year":"2014","unstructured":"Lancaster, M. A. & Knoblich, J. A. Generation of cerebral organoids from human pluripotent stem cells. Nat. Protoc. 9, 2329\u20132340 (2014).","journal-title":"Nat. Protoc."},{"key":"8855_CR57","doi-asserted-by":"crossref","unstructured":"Gentile, S. Antipsychotic therapy during early and late pregnancy. A systematic review. Schizophrenia bulletin 36, 518\u2013544. (2010).","DOI":"10.1093\/schbul\/sbn107"},{"key":"8855_CR58","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3109\/0886022X.2014.900403","volume":"36","author":"M Akar","year":"2014","unstructured":"Akar, M. et al. Transient nephrogenic diabetes insipidus caused by fetal exposure to haloperidol. Ren. Fail. 36, 951\u2013952 (2014).","journal-title":"Ren. Fail."},{"key":"8855_CR59","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/sj.npp.1300023","volume":"28","author":"DE Casey","year":"2003","unstructured":"Casey, D. E. et al. Effect of divalproex combined with olanzapine or Risperidone in patients with an acute exacerbation of schizophrenia. Neuropsychopharmacology 28, 182\u2013192 (2003).","journal-title":"Neuropsychopharmacology"},{"key":"8855_CR60","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/nature22047","volume":"545","author":"G Quadrato","year":"2017","unstructured":"Quadrato, G. et al. Cell diversity and network dynamics in photosensitive human brain organoids. Nature 545, 48\u201353 (2017).","journal-title":"Nature"},{"key":"8855_CR61","first-page":"977","volume":"24","author":"S-J Yoon","year":"2019","unstructured":"Yoon, S-J. et al. Modeling alzheimer\u2019s disease with patient-derived brain organoids. Cell. Stem Cell. 24, 977\u2013993 (2019).","journal-title":"Cell. Stem Cell."},{"key":"8855_CR62","first-page":"e4608","volume":"14","author":"R Sebastian","year":"2024","unstructured":"Sebastian, R. et al. Method to generate dorsal forebrain brain organoids from human pluripotent stem cells. Bio-protocol 14, e4608 (2024).","journal-title":"Bio-protocol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08855-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08855-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08855-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T14:11:37Z","timestamp":1757254297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08855-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,17]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8855"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08855-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,17]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"25945"}}